Paladin Launches Seasonale in Canada

Pharmaceutical company Paladin Labs has announced the Canadian launch of Seasonale, claimed to be the first and only extended-cycle oral contraceptive available in this country.

The company said that, with Seasonale (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets), Canadian women now have a new contraceptive option that will allow them to have just four periods per year.

Jonathan Goodman, president and CEO of Paladin, said: “We are very pleased to have strengthened our women’s health franchise with the addition of Seasonale. With approximately 3,600 physicians writing 50% of the prescriptions in Canada, Seasonale is a clear therapeutic fit for Paladin. As such, we are very excited to be bringing this exclusive product to Canadian women and believe that this next-generation oral contraceptive option will be the preferred choice of many.”